H.R. 8734: To express the Sense of Congress with respect to safety of medication abortion and Federal preemption of State restrictions on dispensing medication abortion, and for other purposes.
This bill, titled HR 8734, expresses the viewpoint of Congress regarding medication abortion and sets forth provisions regarding federal and state laws. Here are the main points:
1. Safety of Medication Abortion
The bill states the following:
- Medication abortion is considered a very safe medical treatment.
- This safety has been recognized by the Commissioner of Food and Drugs, who approved it based on scientific evidence, following the Federal Food, Drug, and Cosmetic Act.
2. Federal Preemption of State Laws
The bill asserts that the federal approval of medication abortion supersedes state laws in certain areas. Specifically:
- States cannot require that medication abortion be dispensed only in person by a healthcare practitioner.
- States cannot impose restrictions or prohibitions on prescribing or dispensing medication abortion through telehealth services.
3. Implications
This legislation aims to ensure that individuals have access to medication abortion without being hindered by state-level restrictions. By emphasizing the safety of this medical procedure and clarifying the federal authority over related state laws, the bill seeks to standardize the availability of medication abortion across the United States.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
22 bill sponsors
-
TrackPatrick Ryan
Sponsor
-
TrackYassamin Ansari
Co-Sponsor
-
TrackSuzanne Bonamici
Co-Sponsor
-
TrackJanelle Bynum
Co-Sponsor
-
TrackJudy Chu
Co-Sponsor
-
TrackLizzie Fletcher
Co-Sponsor
-
TrackJohn Garamendi
Co-Sponsor
-
TrackJared F. Golden
Co-Sponsor
-
TrackJared Huffman
Co-Sponsor
-
TrackHenry C. "Hank" Johnson, Jr.
Co-Sponsor
-
TrackJohn B. Larson
Co-Sponsor
-
TrackBetty McCollum
Co-Sponsor
-
TrackSeth Moulton
Co-Sponsor
-
TrackJerrold Nadler
Co-Sponsor
-
TrackEleanor Holmes Norton
Co-Sponsor
-
TrackDeborah K. Ross
Co-Sponsor
-
TrackLateefah Simon
Co-Sponsor
-
TrackMark Takano
Co-Sponsor
-
TrackDina Titus
Co-Sponsor
-
TrackGabe Vasquez
Co-Sponsor
-
TrackJames R. Walkinshaw
Co-Sponsor
-
TrackNikema Williams
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| May. 11, 2026 | Introduced in House |
| May. 11, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.